| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |